The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.A COVID-19 vaccine that can be produced locally in low- and middle-income countries is yielding promising results in early clinical trials, researchers say.
"The NDV-HXP-S vaccine induced neutralizing antibody responses against wild type SARS-CoV-2 that matched what we see after mRNA vaccination, but the proportion of neutralizing antibodies in the response was higher for NDV-HXP-S," said Mount Sinai's Florian Krammer. The vaccine can be manufactured like flu vaccines at low cost in chicken eggs at influenza vaccine manufacturing plants around the world, his team said.
"This strategy is likely to confer long-lasting and cross-reactive memory that can be quickly restimulated to prevent viral spread," study leader Akiko Iwasaki of Yale University explained on Twitter."The intranasal spike protein booster will also be much easier to administer ... and is much more likely to be accepted by people who are hesitant of mRNA or those with needle phobia.
No, thank you. You've put enough crap into everyone. The offspring of the population will be cursing these scientist for generations.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: STForeignDesk - 🏆 4. / 71 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: STForeignDesk - 🏆 4. / 71 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: STForeignDesk - 🏆 4. / 71 Read more »
Source: STForeignDesk - 🏆 4. / 71 Read more »